NZ631118A - Methods for treating nasal polyposis by administering an il-4r antagonist - Google Patents
Methods for treating nasal polyposis by administering an il-4r antagonistInfo
- Publication number
- NZ631118A NZ631118A NZ631118A NZ63111814A NZ631118A NZ 631118 A NZ631118 A NZ 631118A NZ 631118 A NZ631118 A NZ 631118A NZ 63111814 A NZ63111814 A NZ 63111814A NZ 631118 A NZ631118 A NZ 631118A
- Authority
- NZ
- New Zealand
- Prior art keywords
- administering
- nasal polyposis
- antagonist
- methods
- treating nasal
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ752224A NZ752224B2 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837912P | 2013-06-21 | 2013-06-21 | |
| EP14305670 | 2014-05-07 | ||
| PCT/US2014/043440 WO2014205365A1 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ631118A true NZ631118A (en) | 2019-05-31 |
Family
ID=66440559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ631118A NZ631118A (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Country Status (10)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116203244B (zh) * | 2022-03-30 | 2025-06-27 | 首都医科大学附属北京同仁医院 | 一种无创诊断2型慢性鼻窦炎伴鼻息肉的试剂盒 |
| CN116819076A (zh) * | 2023-05-26 | 2023-09-29 | 首都医科大学附属北京同仁医院 | 一种预测或评估抗IL-4Rα单抗在治疗慢性鼻窦炎伴鼻息肉中疗效的生物标志物、应用和方法 |
| CN117368487A (zh) * | 2023-09-28 | 2024-01-09 | 首都医科大学附属北京同仁医院 | 一种利用局部IgE预测或评估奥马珠单抗在治疗复发性鼻息肉中疗效的方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| WO2010120511A2 (en) * | 2009-03-31 | 2010-10-21 | Altair Therapeutics, Inc. | Method of treating respiratory disorders |
| UA111731C2 (uk) * | 2010-10-06 | 2016-06-10 | Рідженерон Фармасьютікалз, Інк. | Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти |
| CN105517570B (zh) * | 2013-06-21 | 2020-04-07 | 赛诺菲生物技术公司 | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 |
-
2014
- 2014-06-20 TW TW108101935A patent/TWI707694B/zh active
- 2014-06-20 NZ NZ631118A patent/NZ631118A/en unknown
- 2014-06-20 LT LTEP14742021.0T patent/LT3010539T/lt unknown
- 2014-06-20 SG SG10201912898XA patent/SG10201912898XA/en unknown
- 2014-06-20 HR HRP20191709 patent/HRP20191709T1/hr unknown
- 2014-06-20 PT PT147420210T patent/PT3010539T/pt unknown
- 2014-06-20 ES ES14742021T patent/ES2747630T3/es active Active
- 2014-06-20 DK DK14742021.0T patent/DK3010539T3/da active
- 2014-06-20 HU HUE14742021A patent/HUE046410T2/hu unknown
-
2018
- 2018-12-27 JP JP2018243929A patent/JP6640977B2/ja active Active
-
2019
- 2019-12-25 JP JP2019233649A patent/JP6898421B2/ja active Active
-
2021
- 2021-06-09 JP JP2021096260A patent/JP2021138743A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2747630T3 (es) | 2020-03-11 |
| JP2021138743A (ja) | 2021-09-16 |
| JP6640977B2 (ja) | 2020-02-05 |
| PT3010539T (pt) | 2019-10-14 |
| JP2019069987A (ja) | 2019-05-09 |
| SG10201912898XA (en) | 2020-02-27 |
| TWI707694B (zh) | 2020-10-21 |
| HUE046410T2 (hu) | 2020-03-30 |
| NZ752224A (en) | 2020-11-27 |
| LT3010539T (lt) | 2019-10-10 |
| TW201940193A (zh) | 2019-10-16 |
| HRP20191709T1 (hr) | 2019-12-13 |
| JP6898421B2 (ja) | 2021-07-07 |
| DK3010539T3 (da) | 2019-10-21 |
| JP2020073525A (ja) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014284235B2 (en) | Methods for treating nasal polyposis by administering an IL-4R antagonist | |
| NZ706377A (en) | Il-6 antagonists and uses thereof | |
| AU2018253544A1 (en) | Methods for treating or preventing asthma by administering an IL-4R antagonist | |
| MX2017006286A (es) | Metodos para tratar sinusitis cronica con polipos nasales por administracion de un antagonista de il-4r. | |
| PH12014500089A1 (en) | Antibodies that bind to ox40 and their uses | |
| PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
| PH12015500390B1 (en) | Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis | |
| PH12013502201A1 (en) | Anti-b7-h3 antibody | |
| CA2813849C (en) | Secukinumab for use in the treatment of ankylosing spondylitis | |
| TN2015000247A1 (en) | Bcma antigen binding proteins | |
| TN2014000120A1 (en) | Cd27l antigen binding proteins | |
| MX341076B (es) | Formulaciones estables de anticuerpos para el receptor humano pd-1 de meurte programada y tratamientos relacionados. | |
| PH12015501505B1 (en) | Antibodies that bind to tl1a and their uses | |
| EP4382164A3 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| PH12014501783B1 (en) | Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody | |
| PH12014500932A1 (en) | Antibodies specific for trop-2 and their uses | |
| CY1122132T1 (el) | Μεθοδοι για τη μειωση των ρυθμων εξαρσης του ασθματος με χρηση μπενραλιζουμαμπης | |
| MY163953A (en) | Methods of inhibiting tumor growth by antagonizing il-6 receptor | |
| NZ629553A (en) | Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof | |
| MY184189A (en) | Methods of treating nail and scalp psoriasis | |
| MX2015005756A (es) | Proteinas de unión a antígeno anti-her3/her4 de unión a la horquilla beta de her3 y a la horquilla beta de her4. | |
| NZ631118A (en) | Methods for treating nasal polyposis by administering an il-4r antagonist | |
| MX2016014726A (es) | Proteinas de union al antigeno her1 que se unen a la beta-horquilla de her1. | |
| HK1243716A1 (zh) | 通過施用il-4r拮抗劑用於治療伴隨鼻息肉的慢性鼻竇炎的方法 | |
| MX2019009243A (es) | Antagonistas il-4r para usarse en el tratamiento o previncion de asma persistente y asma severa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: REGENERON PHARMACEUTICALS, INC., US Effective date: 20161201 Owner name: SANOFI BIOTECHNOLOGY, FR Effective date: 20161201 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 20 JUN 2021 BY WATERMARK INTELLECTUAL PROPERTY PTY LTD. Effective date: 20190911 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2022 BY CPA GLOBAL Effective date: 20210506 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2023 BY CPA GLOBAL Effective date: 20220505 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2024 BY CPA GLOBAL Effective date: 20230504 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240509 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 JUN 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20250508 |